I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.
The proposed transaction (the “Transaction”) concerns the indirect acquisition of joint control over Medical Technology and Devices SA (“MTD”) by QuattroR SGR S.p.A. (“QuattroR”) and International Medical Technology Collective S.C.A., an independently managed subsidiary of the Investindustrial group (“Investindustrial”).
QuattroR is a management company controlled by its partners, which manages “Fondo QuattroR”, an Italian private equity fund set up in 2017. The mission of QuattroR is to invest in and relaunch businesses with solid market and industrial fundamentals that need fresh resources for growth or are facing temporary financial unbalance. QuattroR currently controls five portfolio companies, whose activities are engineering and logistics solutions, ceramic tiles and wall surfaces, fashion, pulp and paper, and processing and packaging of tomatoes.
Investindustrial is a European investment group of independently managed investment, holding and financial advisory companies. Its portfolio focuses on four main investment areas, i.e. consumer and leisure, healthcare and services, industrial manufacturing, and technology.
MTD, a Swiss-based med-tech group that designs, develops, and provides globally a full range of medical devices for the professional sector and for at home use: diabetes management devices, standard and safety sharp devices, electro-medical devices, wound care products, and other solutions.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.